News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

How Do Lactobacilli Treat Helicobacter pylori-related Diseases?

September 10, 2008
Article

Some studies have demonstrated H. pylori stimulates the release of interleukin-8 (IL-8) from gastric epithelia, which initiates inflammatory damage to gastric mucosa and plays a crucial role in the pathogenesis of H. pylori infections. H. pylori lipopolysaccharide (H. pylori-LPS) is the major initiator in H. pylori-induced IL-8 production via activation of Toll-like receptor 4 (TLR4) pathway in gastric epithelia.

Considering the novel finding that H. pylori is an indigenous biota in gastric microflora including Lactobacilli and hypothesis that the disturbance of gastric microecosystem plays a more important role in pathogenetic mechanisms of H. pylori, the eradiation of H. pylori doesn't seem justified to everyone. The speculation on validity of restoration of the gastric microecosystem has been demonstrated by therapeutic effects of Lactobacilli administration on H. pylori-associated diseases. But whether Lactobacilli inhibit H. pylori-LPS-induced IL-8 production through blocking H. pylori-LPS-activated TLR4 pathway hasn't been well researched.

A research article published Aug. 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Hong-Sheng Ma from West China Hospital of Sichuan University treated SGC-7901 cells with H. pylori Sydney strain 1 lipopolysaccharide (H. pyloriSS1-LPS) in the absence or presence of a pretreatment with viable Lactobacillus bulgaricus (LBG).

The results indicated that viable LBG prevented H. pyloriSS1-LPS-activated TLR4 pathway in SGC-7901 cells, leading to its inhibitory effect on IL-8 production stimulated by H. pyloriSS1-LPS. Considering some evidence implied that supernatant recovered from Lactobacilli culture MRS broth contained some latent soluble proteins secreted by Lactobacilli, SGC-7901 cells were treated with H. pyloriSS1-LPS in the absence or presence of a pretreatment with supernatant recovered from LBG culture MRS broth (LBG-S). It was demonstrated that LBG-S had the same inhibitory effect on H. pyloriSS1-LPS-activated TLR4 signaling transduction as viable LBG.

In a recent novel study, two soluble proteins with molecular sizes of 75 and 40 kDa were purified from supernatant recovered from Lactobacillus rhamnosus GG culture MRS broth and named p75 and p40 respectively, which ameliorated apoptosis of intestinal epithelia treated with tumor necrosis factor α, interferon-γ or IL-1α and promoted cell growth through activating Akt and blocking p38 mitogen-activated protein kinase and stress-activated protein kinase/c-Jun amino-terminal kinase signaling. So LBG-S in this experiment probably contained the similar or even same proteins, which could intervene in H. pyloriSS1-LPS-activated TLR4 signaling through modulating other pathways in SGC-7901 cells.

This evaluation of LBG as a probiotic model revealed an important and novel relationship between H. pylori-LPS-activated TLR4 signaling and selective microflora. This report adds to our understanding of the signal pathways in the gastric epithelia involved in inflammatory responses that are regulated by probiotics and pathogenic bacteria composing the gastric microecosystem. Further studies of the soluble components secreted by Lactobacilli may benefit to the exploration of new drugs against H. pylori-associated diseases in the future.

Reference: Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS. Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol 2008; 14(32): 5090-5095.

 

 

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!
Recent Videos
Infection Control Today's Bug of the Month
Bug of the Month: Ancient Threats Still Linger
Eddie Jay LeCastillo, MSN, RN, CNL, CRRN, CIC, LTC-CIP
From Custody Health to Hospital Infection Control: One Nurse’s Journey and Policy-Driven Impact
40th Anniversary of Metrex  (Image courtesy of Metrex)
Metrex Celebrates 40 Years of Infection Prevention Excellence
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)
Unauthorized UVC Devices in Health Care Pose Legal and Safety Risks
 Futuristic UV Sanitizer with Sleek Design on a white background. (Adobe Stock 1375983522 by Napa)
FDA Clearance Marks a New Era for UVC Disinfection in Health Care
Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)
From Awareness to Action: Educating Staff on Sharps Safety Standards
Amanda Heitman, BSN, RN, CNOR (Photo courtesy of Amanda Heitman)
Championing Surgical Safety: A Perioperative Nurse’s Perspective on Infection Prevention
Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)
Sharps Safety Starts With Communication, Not Just Devices
DJ Shannon, MPH, CIC, VA-BC, FAPIC
All About APIC’s New Guide That Tackles All Catheter-Associated Bloodstream Infections
Jordan Bastian, MPH, CIC, at APIC25
Germs in the Halls: Why Infection Preventionists Are Going Back to School
Related Content
Advertisement

White KN95 or N95 mask with antiviral medical mask for protection against coronavirus on blue background.  (Adobe Stock 340061303 by Dan74)

From Pandemic to Endemic: How the Protective Face Mask Market Is Evolving

Simran Paryani
August 2nd 2025
Article

Once a symbol of crisis, face masks have evolved into everyday essentials—driven not only by pandemic preparedness but by rising air pollution, cultural shifts, and workplace safety regulations. As innovation and demand grow worldwide, the protective face mask market is poised for long-term expansion well beyond COVID-19.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.    (Adobe Stock 1521632893 by Maksim)

Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge

Tori Whitacre Martonicz
August 2nd 2025
Podcast

Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.


Sterile Processing Perspectives With Marjorie Wall, EDBA, MLOS, CRCST, CIS, CHL, CSSBB

The Green Revolution in SPD: From Hidden Cost to Frontline Change

Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB
August 2nd 2025
Article

As climate change accelerates, health care’s environmental impact faces increased scrutiny, with sterile processing departments (SPDs) emerging as key change agents. Often behind the scenes, SPD professionals can lead sustainability by turning routine practices into ecofriendly protocols that protect both patient and planetary health.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.    (Adobe Stock 1521632893 by Maksim)

Building a Culture of Sharps Safety Requires More Than Just Tools

Tori Whitacre Martonicz
August 2nd 2025
Podcast

Sharps safety isn’t just an operating room issue—it’s a system-wide concern that demands stronger policies, consistent reporting, and cross-departmental collaboration to truly protect health care workers.


The US Department of Health and Human Services (HHS)  (Adobe Stock unknown)

HHS Unveils $100M Pilot to Eliminate Hepatitis C in High-Risk Populations: What IPC Professionals Need to Know

Infection Control Today® Editorial Staff
August 2nd 2025
Article

The HHS has launched a $100 million pilot program to eliminate hepatitis C in high-risk populations, an effort that infection prevention professionals can help shape by extending control strategies beyond hospital walls and into underserved communities.


Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist in Atlanta, Georgia.

Better Alerts, Better Cleaning: Why IFU Updates and Borescope Protocols Must Be Built Into SPD Workflows

Tori Whitacre Martonicz
August 2nd 2025
Article

Sterile processing departments are facing a new standard: clean is not clean unless you can see it. At HSPA 2025, experts emphasized that updated IFUs and borescope inspections must be built into routine workflows, not as extra tasks, but as core components of quality control and infection prevention.

Related Content
Advertisement

White KN95 or N95 mask with antiviral medical mask for protection against coronavirus on blue background.  (Adobe Stock 340061303 by Dan74)

From Pandemic to Endemic: How the Protective Face Mask Market Is Evolving

Simran Paryani
August 2nd 2025
Article

Once a symbol of crisis, face masks have evolved into everyday essentials—driven not only by pandemic preparedness but by rising air pollution, cultural shifts, and workplace safety regulations. As innovation and demand grow worldwide, the protective face mask market is poised for long-term expansion well beyond COVID-19.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.    (Adobe Stock 1521632893 by Maksim)

Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge

Tori Whitacre Martonicz
August 2nd 2025
Podcast

Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.


Sterile Processing Perspectives With Marjorie Wall, EDBA, MLOS, CRCST, CIS, CHL, CSSBB

The Green Revolution in SPD: From Hidden Cost to Frontline Change

Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB
August 2nd 2025
Article

As climate change accelerates, health care’s environmental impact faces increased scrutiny, with sterile processing departments (SPDs) emerging as key change agents. Often behind the scenes, SPD professionals can lead sustainability by turning routine practices into ecofriendly protocols that protect both patient and planetary health.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.    (Adobe Stock 1521632893 by Maksim)

Building a Culture of Sharps Safety Requires More Than Just Tools

Tori Whitacre Martonicz
August 2nd 2025
Podcast

Sharps safety isn’t just an operating room issue—it’s a system-wide concern that demands stronger policies, consistent reporting, and cross-departmental collaboration to truly protect health care workers.


The US Department of Health and Human Services (HHS)  (Adobe Stock unknown)

HHS Unveils $100M Pilot to Eliminate Hepatitis C in High-Risk Populations: What IPC Professionals Need to Know

Infection Control Today® Editorial Staff
August 2nd 2025
Article

The HHS has launched a $100 million pilot program to eliminate hepatitis C in high-risk populations, an effort that infection prevention professionals can help shape by extending control strategies beyond hospital walls and into underserved communities.


Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist in Atlanta, Georgia.

Better Alerts, Better Cleaning: Why IFU Updates and Borescope Protocols Must Be Built Into SPD Workflows

Tori Whitacre Martonicz
August 2nd 2025
Article

Sterile processing departments are facing a new standard: clean is not clean unless you can see it. At HSPA 2025, experts emphasized that updated IFUs and borescope inspections must be built into routine workflows, not as extra tasks, but as core components of quality control and infection prevention.

Advertisement
Advertisement
Advertisement
x
Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News